Any clinical manufacturing workflow should incorporate equipment and reagents suitable for clinical manufacturing. This has become especially prominent recently, following the successes achieved by CAR T cell therapy, as regulatory agencies implement more stringent requirements to standardize cell therapy manufacturing. 

Download this application note from Thermo Fisher Scientific to explore new manufacturing solutions—such as a large-volume electroporation system—that provide streamlined clinical cell therapy manufacturing.

Sponsored by